Introduction

Proteins that are present in cyanobacteria and Specific algae like glaucocystophytes, cryptomonads and rhodophytes are called as Phycobiliprotein. These algae that captures the sunlight and passes on to chlorophyll in the course of photosynthesis. Phycobiliproteins are water-soluble proteins. Phycobiliproteins are composed of a proteins and covalently bounded phycobilins that captures light energy. It comprises of the very crucial part if the phycobilisomes.

Due to their role in light gathering, phycobiliproteins have progressed to exploit both fluorescence and absorption and also to reduce the slaking caused because of internal energy transfer or by outer factors such as changes in ionic composition or pH.

These Phycobiliproteins have numerous benefits when used for fluorescent probes, including, powerful long-wavelength emission and excitation so as to provide fluorescence, very high solubility in water, homogeneous structure with defined molecular weights and multiple sites for stable conjugation to many biological and synthetic materials.

Phycobiliproteins undergoes some fluorescence loss upon freezing. The purest form of proteins are stored in suspension ammonium sulfate These compounds when kept in ammonium sulphate are likely to be stable for a time span of about an year when it is stored at 4°C.

The modified derivatives and conjugates are transported in solutions of sodium azide in order to inhibit growth of bacteriaand typically can be stored upto 6 months. All phycobiliproteins and their derivatives should be never be never frozen but should be refrigerated.

The global Phycobiliprotein Conjugates Market is segmented on the basis of techniques, applications and end user.

On the basis of types	Reactive Phycobiliprotein Derivative Phycobiliprotein-Labeled Secondary Detection Reagents Tandem Conjugates of Phycobiliproteins
On the basis of application	Diagnostics Research and development Drug discovery
On the basis of end user	Biotechnology companies Academic institutes Clinical research organizations

The global Phycobiliprotein Conjugates Market is expected to register a significant CAGR over a forecast period. The funding by the various regulatory bodies and governments also expected to bolster the growth of the global Phycobiliprotein Conjugates Market. However, the high cost of reagents and devices required for Phycobiliprotein Conjugates may hamper the growth of the global Phycobiliprotein Conjugates Market.

The stringent rules and regulatory guidance by the U.S. Food and Drug Administration (FDA), may also hinder the growth of the global Phycobiliprotein Conjugates Market. The lack of skilled personnel to perform the detection, also restrain the growth of the global Phycobiliprotein Conjugates Market over a forecast period.

On the basis of regional presence, the global Phycobiliprotein Conjugates Market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The North America is dominating and contributed the leading shares to the Phycobiliprotein Conjugates Market in terms of revenue and expected to register a significant growth over a forecast period due to the developed laboratory infrastructure and availability of skilled personnel in the region.

The Europe has also contributed the moderate shares and registered a healthy growth rate to the global Phycobiliprotein Conjugates Market followed by North America. The APEJ has become the lucrative market for live cell RNA detection and anticipated to register significant shares over the forecast period due to the increasing research and development activities along with government support and funding in the region. The Latin America and MEA are at a nascent stage to the global Phycobiliprotein Conjugates Market and expected to show a moderate growth over a forecast period.

Some of the market players in Phycobiliprotein Conjugates Market globally include Thermo Electron GmBH, Sigma-Aldrich Co. LLC., AAT Bioquest, Inc., AnaSpec, Inc, Jackson ImmunoResearch Inc., and Innova Biosciences Ltd.. The market is currently witnessing a number of strategic collaboration and partnership activities by pharmaceutical and biotechnology companies.